http://www.breakthrough.org.uk/go.rm?id=6082 News and media responses http://www.breakthrough.org.uk/user_config/logo.gif http://www.breakthrough.org.uk/go.rm?id=6082 http://www.breakthrough.org.uk/go.rm?id=12280 http://www.breakthrough.org.uk/go.rm?id=12280 Scientists have found nine new genes which drive the development of breast cancer, in a major study funded by the Wellcome Trust and Breakthrough Breast Cancer. Wed, 16 May 2012 00:00:00 -0100 http://www.breakthrough.org.uk/go.rm?id=12204 http://www.breakthrough.org.uk/go.rm?id=12204 A US study has been published looking at breast screening of women in their 40s. Thu, 03 May 2012 00:00:00 -0100 http://www.breakthrough.org.uk/go.rm?id=12205 http://www.breakthrough.org.uk/go.rm?id=12205 New research raises the possibility of identifying which breast cancer patients could benefit from a promising new drug. Thu, 03 May 2012 00:00:00 -0100 http://www.breakthrough.org.uk/go.rm?id=12199 http://www.breakthrough.org.uk/go.rm?id=12199 New research suggests that a genetic test could be used to predict a woman's chance of getting breast cancer before the disease is diagnosed. Tue, 01 May 2012 00:00:00 -0100 http://www.breakthrough.org.uk/go.rm?id=12195 http://www.breakthrough.org.uk/go.rm?id=12195 A drug combination for patients with advanced breast cancer has not been recommended for approval by NICE (the National Institute for Health and Clinical Excellence). Fri, 27 Apr 2012 00:00:00 -0100 http://www.breakthrough.org.uk/go.rm?id=12189 http://www.breakthrough.org.uk/go.rm?id=12189 Head of Policy at Breakthrough Breast Cancer, Dr Sarah Rawlings, appeared on BBC One's The One Show to take part in a discussion about the National Breast Screening Programme and the review of it. Breakthrough Breast Cancer has pulled together the below information for anyone who may have concerns or queries about screening. Tue, 24 Apr 2012 00:00:00 -0100 http://www.breakthrough.org.uk/go.rm?id=12179 http://www.breakthrough.org.uk/go.rm?id=12179 Response to NICE?s decision to open a consultation on new, draft guidance which does not recommend bevacizumab for the first-time treatment of metastatic breast cancer, when used in combination with the chemotherapy drug, capecitabine. Wed, 18 Apr 2012 00:00:00 -0100 http://www.breakthrough.org.uk/go.rm?id=12183 http://www.breakthrough.org.uk/go.rm?id=12183 Today sees some important new results published in Nature, from a study that has been carried out by Cancer Research UK. Wed, 18 Apr 2012 00:00:00 -0100 http://www.breakthrough.org.uk/go.rm?id=12174 http://www.breakthrough.org.uk/go.rm?id=12174 An exciting new way to potentially beat breast cancer is being discussed in a major international conference in Manchester from Sunday 15 to Wednesday 18 April. Fri, 13 Apr 2012 00:00:00 -0100 http://www.breakthrough.org.uk/go.rm?id=12129 http://www.breakthrough.org.uk/go.rm?id=12129 Scientists have found the first direct link between breast cancer risk and genetically-determined levels of the hormone oestrogen in younger women, according to a paper published online in the Journal of the National Cancer Institute. Thu, 05 Apr 2012 00:00:00 -0100